Corticosteroids in Duchenne muscular dystrophy: Major variations in practice-Reference-Cited by-同舟云学术

Corticosteroids in Duchenne muscular dystrophy: Major variations in practice

Published:2013-04-25 Issue:1 Volume:48 Page:27-31
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle Nerve

Author:

Griggs Robert C.¹,Herr Barbara E.¹,Reha Allen²,Elfring Gary²,Atkinson Leone²,Cwik Valerie³,Mccoll Elaine⁴,Tawil Rabi¹,Pandya Shree¹,McDermott Michael P.¹,Bushby Kate⁴

Affiliation:

1. University of Rochester; Departments of Neurology and Biostatistics, 265 Crittenden Boulevard, CU 420669 Rochester New York 14642 USA

2. PTC Therapeutics; South Plainfield New Jersey USA

3. Muscular Dystrophy Association; Tucson Arizona USA

4. University of Newcastle upon Tyne, International Centre for Life; Institute of Genetic Medicine, Newcastle upon Tyne UK

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Neurology (clinical),Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mus.23831/fullpdf

Reference37 articles.

1. Evidence-based path to newborn screening for Duchenne muscular dystrophy;Mendell;Ann Neurol,2012

2. Duchenne dystrophy: patterns of clinical progression and effects of supportive therapy;Brooke;Neurology,1989

3. Impact of nasal ventilation on survival in hypercapnic Duchenne muscular dystrophy;Simonds;Thorax,1998

4. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation;Eagle;Neuromuscul Disord,2002

5. Duchenne muscular dystrophy: survival by cardiorespiratory interventions;Ishikawa;Neuromuscul Disord,2011

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Vamorolone Over 48 Weeks in Boys With Duchenne Muscular Dystrophy;Neurology;2024-03-12

2. Moving Beyond the 2018 Minimum International Care Considerations for Osteoporosis Management in Duchenne Muscular Dystrophy (DMD): Meeting Report from the 3rd International Muscle-Bone Interactions Meeting 7th and 14th November 2022;Journal of Neuromuscular Diseases;2024-01-02

3. Higher Prevalence of Nonsense Pathogenic DMD Variants in a Single-Center Cohort from Brazil: A Genetic Profile Study That May Guide the Choice of Disease-Modifying Treatments;Brain Sciences;2023-10-28

4. Evolving Therapeutic Options for the Treatment of Duchenne Muscular Dystrophy;Neurotherapeutics;2023-10

5. Efficacy of vamorolone in treatment of Duchene muscle dystrophy. A meta-analysis;Frontiers in Neurology;2023-02-01